Research Roundup

OFFICIAL PUBLICATION OF

by its subsidiary APPco

Debbie Rigby 03/03/2020

Debbie Rigby takes a look at the latest in research news The role of sodium glucose cotransporter-2 (SGLT-2) inhibitors in heart failure and chronic kidney disease in type 2 diabetes In addition to effective glycemic control and weight loss, SGLT-2 inhibitor treatment of T2D prevents adverse cardiovascular and renal outcomes in individuals with and without

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Sigma/CWH merger to change pharmacy

Michael Nobody drafts my emails. They are my own words. Yes, so strange that your evidence couldn't be posted! Perhaps…

Anthony Tassone

Sigma/CWH merger to change pharmacy

Prefer to talk to chemist , but unwilling to pay to have that service made available. That's why chemist warehouse…

Bob Tran

Sigma/CWH merger to change pharmacy

Absolutely pathetic excuse by Wesfarmers. They're an ASX heavyweight and they're afraid of a smaller company? The lack of innovation…

Morbidly Obese John

Sigma/CWH merger to change pharmacy

You seen the average wage working for these toxic workplaces in USA? Our toxic workplaces have a lot to catch…

Philip Smith

Research Roundup

Previous No room in the safe for pharmacotherapy poisons

Next Changes to mandatory reporting now in effect

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous No room in the safe for pharmacotherapy poisons

Next Changes to mandatory reporting now in effect

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.